FDA Approves Biorphen
FDA Approves Biorphen (phenylephrine hydrochloride) Ready-to-Use Injection for Hypotension During Anesthesia
DEER PARK, Ill., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical
Kids Trampoline Injuries Take Another Bounce Upwards
FRIDAY, Oct. 25, 2019 -- Trampolines arent just for backyards anymore, and the rise in commercial trampoline parks may be sparking a rise in kids injuries, a new report finds.
"While trampolines are
FDA Approves Beovu (brolucizumab-dbll) for the Treatment of Wet Age-Related Macular Degeneration (AMD)
EAST HANOVER, N.J., Oct. 8, 2019 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Beovu (brolucizum
FDA Approves Scenesse
FDA Approves Scenesse (afamelanotide) for Prevention of Phototoxicity in Erythropoietic Protoporphyria
October 08, 2019 -- The U.S. Food and Drug Administration today granted approval to Scenesse (afamelanotide) to increase pain-
Questions and Answers: NDMA Impurities in Ranitidine (Commonly Known as Zantac)
October 11, 2019
What patients should know about NDMA impurities in ranitidine
Not all ranitidine medicines marketed in the U.S. are being recalled.
FDA does not have